Latest: FDA Approves New Biosimilar for Oncology Treatment

Cervical Cancer Risk Remains High After 65

0 Mins
A comprehensive analysis of 2.1 million Chinese women demonstrates significantly elevated cervical cancer risks in those aged 65 and older, with nearly 9-fold higher cancer detection rates and increased high-risk HPV prevalence compared to younger cohorts. These findings challenge current age-based screening cessation guidelines and suggest physiological changes may impair viral clearance in older women.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago